Michael R. Bleavins

876 total citations
33 papers, 704 citations indexed

About

Michael R. Bleavins is a scholar working on Molecular Biology, Health, Toxicology and Mutagenesis and Oncology. According to data from OpenAlex, Michael R. Bleavins has authored 33 papers receiving a total of 704 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Health, Toxicology and Mutagenesis and 6 papers in Oncology. Recurrent topics in Michael R. Bleavins's work include Toxic Organic Pollutants Impact (5 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Vascular Tumors and Angiosarcomas (2 papers). Michael R. Bleavins is often cited by papers focused on Toxic Organic Pollutants Impact (5 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Vascular Tumors and Angiosarcomas (2 papers). Michael R. Bleavins collaborates with scholars based in United States, Italy and United Kingdom. Michael R. Bleavins's co-authors include R. J. Aulerich, Robert K. Ringer, Felix A. de la Iglesia, Erika Ferguson, T. Jatkoe, Steven J. Bulera, James F. Reindel, Kent J. Johnson, Steven K. Duddy and Joseph R. Piccotti and has published in prestigious journals such as The Journal of Immunology, Hepatology and Journal of Nutrition.

In The Last Decade

Michael R. Bleavins

32 papers receiving 656 citations

Peers

Michael R. Bleavins

HTM

IMMUN

ONCOL

R. L. Gregson United States

M. M. Lipsky United States

Debra Dunlap United States

Esther de Jong Netherlands

Edgar Weber Germany

Nil Turan United Kingdom

Nan Hao Australia

Mary Ann Cox United States

Axel Bube Germany

Roddie C. McKenzie United Kingdom

R. L. Gregson United States

Michael R. Bleavins

202 ×0.8

64 ×0.3

HTM

91 ×0.9

89 ×1.0

IMMUN

85 ×1.2

ONCOL

Citations per year, relative to Michael R. Bleavins Michael R. Bleavins (= 1×) peers R. L. Gregson

Countries citing papers authored by Michael R. Bleavins

Since Specialization

Citations

This map shows the geographic impact of Michael R. Bleavins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael R. Bleavins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael R. Bleavins more than expected).

Fields of papers citing papers by Michael R. Bleavins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael R. Bleavins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael R. Bleavins. The network helps show where Michael R. Bleavins may publish in the future.

Co-authorship network of co-authors of Michael R. Bleavins

This figure shows the co-authorship network connecting the top 25 collaborators of Michael R. Bleavins. A scholar is included among the top collaborators of Michael R. Bleavins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael R. Bleavins. Michael R. Bleavins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bifari, Francesco, et al.. (2022). REL-1017 (Esmethadone), A Novel NMDAR Blocker for the Treatment of MDD is Not Neurotoxic in Sprague-Dawley Rats. Frontiers in Pharmacology. 13. 863959–863959. 8 indexed citations

Bleavins, Michael R.. (2010). Biomarkers in drug development : a handbook of practice, application, and strategy. J. Wiley eBooks. 12 indexed citations

Piccotti, Joseph R., et al.. (2006). Evaluation of an ex vivo murine local lymph node assay: multiple endpoint comparison. Journal of Applied Toxicology. 26(4). 333–340. 9 indexed citations

Olle, Eric W., Arun Sreekumar, Roscoe L. Warner, et al.. (2005). Development of an Internally Controlled Antibody Microarray. Molecular & Cellular Proteomics. 4(11). 1664–1672. 28 indexed citations

Piccotti, Joseph R., et al.. (2005). Induction of Apoptosis by Cationic Amphiphilic Drugs Amiodarone and Imipramine. Drug and Chemical Toxicology. 28(1). 117–133. 36 indexed citations

Shi, Michael, Scott P. Myrand, Michael R. Bleavins, & Felix A. de la Iglesia. (2003). Genotyping for Functionally Important Human CYP2D64 (B) Mutation Using TaqMan Probes. Humana Press eBooks. 49. 459–472. 2 indexed citations

Bulera, Steven J., Erika Ferguson, T. Jatkoe, et al.. (2001). Rna Expression in the Early Characterization of Hepatotoxicants in Wistar Rats by High–Density Dna Microarrays. Hepatology. 33(5). 1239–1258. 141 indexed citations

Criswell, Kay A., Michael A. Breider, & Michael R. Bleavins. (2001). EDTA-Dependent Platelet Phagocytosis. American Journal of Clinical Pathology. 115(3). 376–384. 10 indexed citations

Duddy, Steven K., et al.. (1999). p53 Is Not Inactivated in B6C3F1 Mouse Vascular Tumors Arising Spontaneously or Associated with Long-Term Administration of the Thiazolidinedione Troglitazone. Toxicology and Applied Pharmacology. 156(2). 106–112. 22 indexed citations

10.

Duddy, Steven K., et al.. (1999). Spontaneous and Thiazolidinedione-Induced B6C3F1 Mouse Hemangiosarcomas Exhibit Low ras Oncogene Mutation Frequencies. Toxicology and Applied Pharmacology. 160(2). 133–140. 16 indexed citations

11.

Bless, Nicolas M., Thomas P. Shanley, Larry D. Crouch, et al.. (1999). Regulatory Effects of Endogenous Protease Inhibitors in Acute Lung Inflammatory Injury. The Journal of Immunology. 162(6). 3653–3662. 86 indexed citations

12.

Duddy, Steven K., et al.. (1998). Genetic Analysis of Multiple Loci in Microsamples of Fixed Paraffin-Embedded Tissue. Toxicological Sciences. 46(2). 317–323. 9 indexed citations

13.

Bleavins, Michael R. & Felix A. de la Iglesia. (1995). Cynomolgus monkeys (Macaca fascicularis) in preclinical immune function safety testing: development of a delayed-type hypersensitivity procedure. Toxicology. 95(1-3). 103–112. 10 indexed citations

14.

Robertson, Donald G., et al.. (1995). Changes in Monkey Plasma Purines Induced by Repeated Doses of CI-1000, a Novel Inhibitor of Purine Nucleoside Phosphorylase. Advances in experimental medicine and biology. 370. 173–177. 3 indexed citations

15.

Bleavins, Michael R., et al.. (1993). Flow cytometric characterization of lymphocyte subpopulations in the cynomolgus monkey (Macaca fascicularis). Veterinary Immunology and Immunopathology. 37(1). 1–13. 17 indexed citations

16.

Brott, David, et al.. (1993). Cell cycle dependent distribution of proliferating cell nuclear antigen/cyclin and cdc2‐kinase in mouse T‐lymphoma cells. Journal of Cellular Biochemistry. 52(3). 362–372. 10 indexed citations

17.

Bleavins, Michael R. & Daniel Dziedzic. (1990). An immunofluorescence study of T and B lymphocytes in ozone-induced pulmonary lesions in the mouse. Toxicology and Applied Pharmacology. 105(1). 93–102. 8 indexed citations

18.

Bleavins, Michael R., et al.. (1983). Effects of Excessive Dietary Zinc on the Intrauterine and Postnatal Development of Mink. Journal of Nutrition. 113(11). 2360–2367. 16 indexed citations

19.

Bleavins, Michael R., R. J. Aulerich, & Robert K. Ringer. (1983). Hexachlorobenzene-induced effects on the lymphocyte blastogenic response to concanavalin a in the mink and European ferret. Environmental Toxicology and Chemistry. 2(4). 411–418. 8 indexed citations

20.

Bleavins, Michael R., R. J. Aulerich, & Robert K. Ringer. (1980). Polychlorinated biphenyls (Aroclors 1016 and 1242): Effects on survival and reproduction in mink and ferrets. Archives of Environmental Contamination and Toxicology. 9(5). 627–635. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact